NASDAQ | ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio ofU. S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than 250 million.
The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index.
Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| FGXXX | First American Funds Inc. - Government Obligations Fund | 99.96% | ||
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.27% |
| FATE | Fate Therapeutics Inc | Healthcare | Biotechnology | 2.15% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.98% |
| ITOS | Iteos Therapeutics Inc | Healthcare | Biotechnology | 1.95% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.95% |
| DNA | Ginkgo Bioworks Holdings | Healthcare | Biotechnology | 1.91% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.87% |
| TSVT | 2Seventy Bio Inc | Healthcare | Biotechnology | 1.86% |
| STRO | Sutro Biopharma | Healthcare | Biotechnology | 1.83% |
| ARVN | Arvinas Inc | Healthcare | Biotechnology | 1.80% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.78% |
| IPHA | Innate Pharma | Healthcare | Biotechnology | 1.77% |
| SNDX | Syndax Pharmaceuticals Inc | Healthcare | Biotechnology | 1.76% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.76% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 1.76% |
| NUVB | Nuvation Bio Inc | Healthcare | Biotechnology | 1.75% |
| ELVN | Enliven Therapeutics Inc. | Healthcare | Biotechnology | 1.74% |
| IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 1.74% |
| RCUS | Arcus Biosciences Inc | Healthcare | Biotechnology | 1.74% |